Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa

Int J Epidemiol. 2017 Apr 1;46(2):e21. doi: 10.1093/ije/dyw057.

Authors

Kathryn Stinson^{1

2}, Eric Goemaere^{1

2}, David Coetzee^{2

3}, Gilles van Cutsem^{1

2}, Katherine Hilderbrand^{1

2}, Meg Osler², Claudine Hennessey², Lynne Wilkinson¹, Gabriela Patten¹, Carol Cragg³, Shaheed Mathee³, Vivian Cox¹, Andrew Boulle^{1

2}

Affiliations

¹ Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa.
² Centre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, South Africa and.
³ Department of Health, Provincial Government of the Western Cape, Cape Town, South Africa.

PMID: 27208042
DOI: 10.1093/ije/dyw057

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Anti-Retroviral Agents / therapeutic use*
Antiretroviral Therapy, Highly Active / methods
Child
Child, Preschool
Female
HIV Infections / drug therapy*
HIV Infections / epidemiology*
Humans
Infant
Infant, Newborn
Male
Prospective Studies
South Africa / epidemiology
Young Adult

Substances

Anti-Retroviral Agents